Lucid Diagnostics (LUCD) Change in Accured Expenses (2020 - 2026)

Lucid Diagnostics has reported Change in Accured Expenses for 7 years, with the latest figure at -$519000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 31.35% year-over-year to -$519000.0; the trailing twelve-month figure through Mar 2026 stood at $127000.0 (down 87.61% YoY), and the FY2025 full-year result was -$110000.0, up 89.13% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$519000.0, down from $443000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $7.7 million in Q4 2022, with the low at -$2.9 million in Q4 2023.
• Historically, Change in Accured Expenses has averaged $495588.2 across 5 years, with a median of $113000.0 in 2022.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses plunged 667.06% — and 2023, when it surged 2260.18%.
• Lucid Diagnostics' Change in Accured Expenses stood at $7.7 million in 2022, then sank by 138.3% to -$2.9 million in 2023, then soared by 128.1% to $824000.0 in 2024, then plunged by 46.24% to $443000.0 in 2025, then tumbled by 217.16% to -$519000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$519000.0 (Q1 2026), $443000.0 (Q4 2025), and -$146000.0 (Q3 2025), per Business Quant data.